Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.

about

Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy.

P2860

Q38746270-71A0893B-502A-494F-8043-C9DE52118E9E

P2860

Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.

Item

http://www.wikidata.org/entity/Q39229631

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cholesterol- and blood-pressur ...... revention in 2004-2013 Europe.

@en

Cholesterol- and blood-pressur ...... revention in 2004-2013 Europe.

@nl

type

Item

label

Cholesterol- and blood-pressur ...... revention in 2004-2013 Europe.

@en

Cholesterol- and blood-pressur ...... revention in 2004-2013 Europe.

@nl

prefLabel

Cholesterol- and blood-pressur ...... revention in 2004-2013 Europe.

@en

Cholesterol- and blood-pressur ...... revention in 2004-2013 Europe.

@nl

P1476

Cholesterol- and blood-pressur ...... revention in 2004-2013 Europe.

@en

P2093

Dmitrij Achelrod

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Updated national and international hypertension guidelines: a review of current recommendations

Review of clinical practice guidelines for the management of LDL-related risk

Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Cardiovascular risk and statin use in the United States

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.

Data Resource Profile: the Survey of Health, Ageing and Retirement in Europe (SHARE)

Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5 million people.

P304

426-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2047487316676906

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Preiss

B Mihaylova

Alastair Gray

P577

2016-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27799597

http://www.w3.org/2001/XMLSchema#string

Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.

about

P2860

P2860

Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698